Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-03-16
1990-03-06
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546271, 546343, C07D21330, A61K 3144
Patent
active
049066366
ABSTRACT:
2-Substituted-1-naphthols are 5-lipoxygenase inhibitors which make them useful in the treatment of inflammation, obstructive lung disease and/or psoriasis. Useful 2-substituent groups are alkyls, alkenyls, alkynyls, cycloalkyls, cycloalkenyls, the groups CH.sub.2 --C.tbd.C--(CH.sub.2).sub.m R.sup.5 and CH.dbd.CH--(CH.sub.2).sub.n R.sup.5 (where m is 1-4, n is 0-3 and R.sup.5 includes phenyl, COOR.sup.9, where R.sup.9 is H or alkyl or 1-4 carbons, AR.sup.6 (where A is a methylene chain and R.sup.6 is a variety of groups including Cl, Br, I, CHO, CN, COOR.sup.9, NH.sub.2, SC(NH)NH.sub.2, phenyl, P(O)(OR.sup.9).sub.2, etc.), and CHR.sup.7 R.sup.21 (where R.sup.7 is a variety of aromatic and heterocyclic groups and R.sup.21 is H, optionally substituted phenyl and a variety of heterocyclic groups).
REFERENCES:
patent: 3843664 (1974-10-01), Coombs
patent: 3959308 (1976-05-01), Coombs
patent: 3969415 (1976-07-01), Galantay
patent: 3998966 (1976-12-01), Fried et al.
G. Xi et al. in Yaoxue Xuebao 15, 548 (1980).
T. Nakadate et al., Gann, 75, 214 (1984).
J. Van Wauwe and J. Goossens, Prostaglandins, 26, 725 (1983).
R. V. Panganamala et al., Prostaglandins, 14, 261 (1977).
M. Shiraishi and S. Tereo in J. Chem. Soc. Perkin Trans. I, 1591 (1983).
S. Narasimhan and R. S. Mali, Tetrahedron, 31, 1005 (1975).
Newman et al., J. Org. Chem., 43, 524 (1978).
B. Miller and W. Lin, J. Org. Chem., 43, 4441 (1978).
K. A. Parker and J. L. Kallmerton, Tetrahedron Letters, 14, 1197 (1979).
D. W. Cameron et al., Aust. J. Chem., 35, 1481 (1982).
P. Barua et al., Chem. Ind. 303 (1984).
T. Kometani et al., J. Org. Chem., 48, 2630 (1983).
T. Zhong and M. Huang, Hua Hseuh Hseuh Pao, 39, 229 (1981).
C. Pac et al., Synthesis, 589, (1978).
I. A. Akhtar and J. J. McCullough in J. Org. Chem., 46, 1447 (1981).
R. Alonso Cermona et al., An Quim., Ser. C, 78, 9 (1982).
I. M. Andreeva et al., Khim. Geterotsikl. Soedin. 2, 181 (1983).
D. Berney and K. Schuh, Helv. Chim. Acta, 62, 1268 (1979).
Bagavant, G. et al., Indian Journal of Pharmaceutical Sciences, 1985, 47, pp. 12-15.
S. P. Starkov, Izv. Vyssh. Uchebn. Zaved., Khim. Khim. Tekhnol. 20, 1099 (1977).
M. R. Saida, Indian J. Chem., 474 (1982).
L. Z. Oblasova and G. D. Kharlampovich, Khim. Pro-St. (Moscow), 10, 776 (1977).
F. T. Sher and G. A. Berchtold, J. Org. Chem, 42, 2569 (1977).
M. Mully et al., Helv. Chim. Acta, 58, 610 (1975).
T. R. Kasturi and R. Sivaramakrishnan, Proc. Indian Acad. Sci., 86, 309 (1977).
B. Miller and W. Lin, J. Org. Chem., 44, 887 (1979).
Z. Aizenshtat et al., J. Org. Chem., 42, 2386 (1977).
E. I. Du Pont de Nemours and Company
Shah Mukund J.
Tsung Frederick F.
LandOfFree
2-Substituted-1-naphthols as 5-lipoxygenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-Substituted-1-naphthols as 5-lipoxygenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Substituted-1-naphthols as 5-lipoxygenase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-47653